Lisa Mucha

Summary

Affiliation: Thomson Scientific
Country: UK

Publications

  1. ncbi Per-patient-per-month drug costs in Medicare Part D protected classes
    Lisa Mucha
    Thomson Medstat, Cambridge, MA 02140, USA
    Pharmacoeconomics 24:79-84. 2006
  2. ncbi Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking
    Lisa Mucha
    Pharmaceutical Outcomes Research, Thomson Medstat, 150 Cambridge Park Drive, Cambridge, MA 02140, USA
    Gend Med 3:279-91. 2006
  3. ncbi Racial differences in switching, augmentation, and titration of lipid-lowering agents by Medicare/Medicaid dual-eligible patients
    Tami L Mark
    Am J Manag Care 13:S72-9. 2007
  4. ncbi Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease
    Lisa Mucha
    Global Health Outcomes and Assessment, Wyeth Research, 500 Arcola Rd, Collegeville, PA 19426, USA
    J Manag Care Pharm 14:451-61. 2008

Collaborators

Detail Information

Publications4

  1. ncbi Per-patient-per-month drug costs in Medicare Part D protected classes
    Lisa Mucha
    Thomson Medstat, Cambridge, MA 02140, USA
    Pharmacoeconomics 24:79-84. 2006
    ....
  2. ncbi Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking
    Lisa Mucha
    Pharmaceutical Outcomes Research, Thomson Medstat, 150 Cambridge Park Drive, Cambridge, MA 02140, USA
    Gend Med 3:279-91. 2006
    ..The risks associated with cigarette smoking can be substantial, particularly for females. In 2000, the mortality rate for lung cancer among women was higher than that for breast cancer...
  3. ncbi Racial differences in switching, augmentation, and titration of lipid-lowering agents by Medicare/Medicaid dual-eligible patients
    Tami L Mark
    Am J Manag Care 13:S72-9. 2007
    ..These treatment disparities merit further study, because they may impact dual-eligible patients moving into Medicare Part D plans...
  4. ncbi Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease
    Lisa Mucha
    Global Health Outcomes and Assessment, Wyeth Research, 500 Arcola Rd, Collegeville, PA 19426, USA
    J Manag Care Pharm 14:451-61. 2008
    ..However, the characteristic declines in learning and memory seen in AD may erode the patient's ability to adhere to medication regimens with or without caregiver support...